moxifloxacin has been researched along with Parodontosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Attin, T; Bensland, S; Eick, S; Karygianni, L; Kulik, EM; Thurnheer, T | 1 |
| Al-Waeli, H; Ganguly, A; Ian, CK; Meka, VS; Sahu, PS; Sheshala, R | 1 |
| Cachovan, G; Dogan-Onur, O; Nergiz, I; Oral, O; Platzer, U; Siefert, HM; Sobottka, I; Thuss, U | 1 |
| Blandino, G; Lo Bue, AM; Milazzo, I; Musumeci, R; Nicoletti, G; Speciale, A | 1 |
4 other study(ies) available for moxifloxacin and Parodontosis
| Article | Year |
|---|---|
Antibiotic Resistance among Fusobacterium, Capnocytophaga, and Leptotrichia Species of the Oral Cavity.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Capnocytophaga; Ciprofloxacin; Clindamycin; Doxycycline; Drug Resistance, Bacterial; Fusobacterium; Humans; Leptothrix; Leptotrichia; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Periodontal Diseases | 2023 |
Application of diverse natural polymers in the design of oral gels for the treatment of periodontal diseases.
Topics: Administration, Oral; Aggregatibacter actinomycetemcomitans; Anti-Infective Agents; Biological Products; Chitosan; Diffusion; Fluoroquinolones; Gels; Humans; Hydrogen-Ion Concentration; Karaya Gum; Materials Testing; Moxifloxacin; Periodontal Diseases; Polymers; Streptococcus mutans; Surface Properties; Viscosity | 2017 |
Penetration of moxifloxacin into rat mandibular bone and soft tissue.
Topics: Alveolar Process; Animals; Anti-Infective Agents; Aza Compounds; Fluoroquinolones; Infections; Male; Mandible; Masseter Muscle; Moxifloxacin; Periodontal Diseases; Quinolines; Random Allocation; Rats; Rats, Wistar; Tooth Diseases | 2009 |
Antibacterial activity of moxifloxacin against periodontal anaerobic pathogens involved in systemic infections.
Topics: Anaerobiosis; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Fluoroquinolones; Gram-Negative Anaerobic Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Moxifloxacin; Periodontal Diseases; Quinolines; Time Factors | 2002 |